"Global Ulcerative Colitis Market 2016-2020" now available at Fast Market Research

From: Fast Market Research, Inc.
Published: Thu May 19 2016

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals with the disease. Medications such as 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics are used to treat the disease.

Full Report Details at
- http://www.fastmr.com/prod/1171562_global_ulcerative_colitis.aspx?afid=301

Technavio's analysts forecast the global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.

The market is divided into the following segments based on geography:

* Americas

Technavio's report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* AbbVie
* Janssen Biotech
* Merck
* Takeda Pharmaceuticals

Other prominent vendors

* Abbott
* Ajinomoto Pharmaceuticals
* Amgen
* Arena Pharmaceuticals
* AstraZeneca
* Astellas Pharma
* Avaxia Biologics
* BioLineRx
* Celgene
* Cosmo Pharmaceuticals
* Eisai
* Ferring Pharmaceuticals
* Galapagos
* Genentech
* Gilead Sciences
* GlaxoSmithKline
* Hutchison Medi Pharma
* Immune Pharmaceuticals
* InDex Pharmaceuticals
* Kaken Pharmaceutical
* Kissei Pharmaceutical
* Kyowa Hakko Kirin
* Lipid Therapeutics
* Meda
* Mitsubishi Tanabe
* Mochida Pharmaceutical
* Morphotek
* Nestle
* Pfizer
* Procter & Gamble
* Qu Biologics
* Receptos
* Salix Pharmaceuticals
* Shield Therapeutics
* Shire Pharmaceuticals
* Sterna Biologicals
* Tillotts Pharma
* TopiVert
* Zeria Pharmaceutical

Market driver

* Increase in patient assistance programs
* For a full, detailed list, view our report

Market challenge

* Patent expiries
* For a full, detailed list, view our report

Market trend

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Inflammatory Bowel Disease Market 2015-2019
- Global Ulcerative Colitis Partnering 2010-2016
- Colitis Global Clinical Trials Review, H1, 2016
- Ulcerative Colitis - Pipeline Review, H2 2015
- Ulcerative Colitis: Update Bulletin [Feb 2016]

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »